Guardant Health, Inc.GHNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+30.7%
5Y CAGR+30.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+30.7%/yr
vs +37.9%/yr prior
5Y CAGR
+30.4%/yr
Consistent
Acceleration
-7.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$349.01M+20.4%
2024$289.80M+27.6%
2023$227.05M+45.2%
2022$156.32M+27.2%
2021$122.91M+32.8%
2020$92.53M+30.8%
2019$70.72M+63.7%
2018$43.21M+36.7%
2017$31.62M+42.9%
2016$22.12M-